Abstrakt: |
This article can act as a microRNA guideline for laboratory research and pharmaceutical industries for treating Alzheimer's and Parkinson's diseases and offers the opportunity to evaluate therapeutic interventions earlier in the disease process." Alzheimer Disease, Biomarkers, Brain Diseases and Conditions, Central Nervous System Diseases and Conditions, Dementia, Diagnostics and Screening, Drugs and Therapies, Health and Medicine, Neurodegenerative Diseases and Conditions, Tauopathies Keywords: Alzheimer Disease; Biomarkers; Brain Diseases and Conditions; Central Nervous System Diseases and Conditions; Dementia; Diagnostics and Screening; Drugs and Therapies; Health and Medicine; Neurodegenerative Diseases and Conditions; Tauopathies EN Alzheimer Disease Biomarkers Brain Diseases and Conditions Central Nervous System Diseases and Conditions Dementia Diagnostics and Screening Drugs and Therapies Health and Medicine Neurodegenerative Diseases and Conditions Tauopathies 1555 1555 1 04/24/23 20230428 NES 230428 2023 APR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Data detailed on Alzheimer disease have been presented. [Extracted from the article] |